云中马：12月9日召开董事会会议

Group 1 - The company Yunzhongma (SH 603130) held its 22nd meeting of the third board of directors on December 9, 2025, to review the proposal for revising the "Audit Committee Work Rules" [1] - For the year 2024, Yunzhongma's revenue composition is 99.6% from manufacturing and 0.4% from other businesses [1] - As of the report date, Yunzhongma has a market capitalization of 6.3 billion yuan [1] Group 2 - The article discusses the first reported case of pregabalin abuse leading to addiction in China, highlighting vulnerabilities in online platforms that allow drug purchases without medical records [1]